Home

evita genetic pace gluba brozka markers of increased atherosclerotic risk in patients Voal ajunge din urmă Superioritate

Atherogenic index of plasma as predictors for metabolic syndrome,  hypertension and diabetes mellitus in Taiwan citizens: a 9-year  longitudinal study | Scientific Reports
Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: a 9-year longitudinal study | Scientific Reports

Biomarkers of premature atherosclerosis - ScienceDirect
Biomarkers of premature atherosclerosis - ScienceDirect

Classical and novel cardiovascular risk factors. | Download Scientific  Diagram
Classical and novel cardiovascular risk factors. | Download Scientific Diagram

Clinical outcomes by atherosclerotic cardiovascular disease risk score and  blood pressure level in high risk individuals with type 2 diabetes |  Journal of Human Hypertension
Clinical outcomes by atherosclerotic cardiovascular disease risk score and blood pressure level in high risk individuals with type 2 diabetes | Journal of Human Hypertension

Medical management of risk factors for vascular disease - ScienceDirect
Medical management of risk factors for vascular disease - ScienceDirect

Next Generation Risk Markers in Preventive Cardio-oncology | SpringerLink
Next Generation Risk Markers in Preventive Cardio-oncology | SpringerLink

Bedside quantification of atherosclerosis severity for cardiovascular risk  stratification: a prospective cohort study - ScienceDirect
Bedside quantification of atherosclerosis severity for cardiovascular risk stratification: a prospective cohort study - ScienceDirect

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of  Atherosclerotic Cardiovascular Diseases 2017. - Abstract - Europe PMC
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017. - Abstract - Europe PMC

Cells | Free Full-Text | Scavenger Receptors as Biomarkers and Therapeutic  Targets in Cardiovascular Disease | HTML
Cells | Free Full-Text | Scavenger Receptors as Biomarkers and Therapeutic Targets in Cardiovascular Disease | HTML

Cardiovascular Diseases—A Focus on Atherosclerosis, Its Prophylaxis,  Complications and Recent Advancements in Therapies
Cardiovascular Diseases—A Focus on Atherosclerosis, Its Prophylaxis, Complications and Recent Advancements in Therapies

BIOMARKERS OF CARDIOVASCULAR DISEASE - Scherbak - Physical and  rehabilitation medicine, medical rehabilitation
BIOMARKERS OF CARDIOVASCULAR DISEASE - Scherbak - Physical and rehabilitation medicine, medical rehabilitation

Cardiovascular risk assessment in patients with rheumatoid arthritis using  carotid ultrasound B-mode imaging | SpringerLink
Cardiovascular risk assessment in patients with rheumatoid arthritis using carotid ultrasound B-mode imaging | SpringerLink

Cardiovascular risk assessment in patients with rheumatoid arthritis using  carotid ultrasound B-mode imaging | SpringerLink
Cardiovascular risk assessment in patients with rheumatoid arthritis using carotid ultrasound B-mode imaging | SpringerLink

Nontraditional Risk Factors and Biomarkers for Cardiovascular Disease:  Mechanistic, Research, and Clinical Considerations for Youth | Circulation
Nontraditional Risk Factors and Biomarkers for Cardiovascular Disease: Mechanistic, Research, and Clinical Considerations for Youth | Circulation

Next Generation Risk Markers in Preventive Cardio-oncology | SpringerLink
Next Generation Risk Markers in Preventive Cardio-oncology | SpringerLink

PDF) Emerging Anti-Atherosclerotic Therapies
PDF) Emerging Anti-Atherosclerotic Therapies

Markers of Atherosclerosis: Part 1 – Serological Markers - ScienceDirect
Markers of Atherosclerosis: Part 1 – Serological Markers - ScienceDirect

High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic  Adiposity, Atherogenic Dyslipidemia, and Inflammation | Metabolic Syndrome  and Related Disorders
High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation | Metabolic Syndrome and Related Disorders

JLA :: Journal of Lipid and Atherosclerosis
JLA :: Journal of Lipid and Atherosclerosis

The risk and added values of the atherosclerotic cardiovascular risk  enhancers on prediction of cardiovascular events: Tehran lipid and glucose  study | Journal of Translational Medicine | Full Text
The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study | Journal of Translational Medicine | Full Text

PDF) The Role of Atherosclerotic Cardiovascular Risk Enhancers in the  Prediction of Cardiovascular Events: Tehran Lipid and Glucose Study
PDF) The Role of Atherosclerotic Cardiovascular Risk Enhancers in the Prediction of Cardiovascular Events: Tehran Lipid and Glucose Study

Nontraditional Risk Factors and Biomarkers for Cardiovascular Disease:  Mechanistic, Research, and Clinical Considerations for Youth | Circulation
Nontraditional Risk Factors and Biomarkers for Cardiovascular Disease: Mechanistic, Research, and Clinical Considerations for Youth | Circulation

Next Generation Risk Markers in Preventive Cardio-oncology | SpringerLink
Next Generation Risk Markers in Preventive Cardio-oncology | SpringerLink

2016 European Guidelines on cardiovascular disease prevention in clinical  practice
2016 European Guidelines on cardiovascular disease prevention in clinical practice

Beneficial activities of losmapimod in atherosclerosis. Abbreviation:... |  Download Scientific Diagram
Beneficial activities of losmapimod in atherosclerosis. Abbreviation:... | Download Scientific Diagram

The risk and added values of the atherosclerotic cardiovascular risk  enhancers on prediction of cardiovascular events: Tehran lipid and glucose  study | Journal of Translational Medicine | Full Text
The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study | Journal of Translational Medicine | Full Text